211 related articles for article (PubMed ID: 21246394)
1. Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas.
Chaponis D; Barnes JW; Dellagatta JL; Kesari S; Fast E; Sauvageot C; Panagrahy D; Greene ER; Ramakrishna N; Wen PY; Kung AL; Stiles C; Kieran MW
J Neurooncol; 2011 Aug; 104(1):179-89. PubMed ID: 21246394
[TBL] [Abstract][Full Text] [Related]
2. The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity.
Basso AD; Mirza A; Liu G; Long BJ; Bishop WR; Kirschmeier P
J Biol Chem; 2005 Sep; 280(35):31101-8. PubMed ID: 16006564
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
[TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
Germano IM; Emdad L; Qadeer ZA; Binello E; Uzzaman M
Cancer Gene Ther; 2010 Sep; 17(9):664-74. PubMed ID: 20523363
[TBL] [Abstract][Full Text] [Related]
5. Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.
Gramatzki D; Herrmann C; Happold C; Becker KA; Gulbins E; Weller M; Tabatabai G
PLoS One; 2013; 8(5):e63527. PubMed ID: 23667632
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
Koukourakis GV; Kouloulias V; Zacharias G; Papadimitriou C; Pantelakos P; Maravelis G; Fotineas A; Beli I; Chaldeopoulos D; Kouvaris J
Molecules; 2009 Apr; 14(4):1561-77. PubMed ID: 19384285
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
8. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
9. Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy.
Yamini B; Yu X; Pytel P; Galanopoulos N; Rawlani V; Veerapong J; Bickenbach K; Weichselbaum RR
Clin Cancer Res; 2007 Oct; 13(20):6217-23. PubMed ID: 17947489
[TBL] [Abstract][Full Text] [Related]
10. Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model.
Dagıstan Y; Karaca I; Bozkurt ER; Ozar E; Yagmurlu K; Toklu A; Bilir A
Acta Cir Bras; 2012 Jun; 27(6):383-7. PubMed ID: 22666755
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.
Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS
J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233
[TBL] [Abstract][Full Text] [Related]
12. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
14. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.
Momota H; Nerio E; Holland EC
Cancer Res; 2005 Aug; 65(16):7429-35. PubMed ID: 16103096
[TBL] [Abstract][Full Text] [Related]
15. Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models.
Chen TC; Wang W; Golden EB; Thomas S; Sivakumar W; Hofman FM; Louie SG; Schönthal AH
Cancer Lett; 2011 Mar; 302(2):100-8. PubMed ID: 21257259
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy in high-grade gliomas.
Ulutin C
Tumori; 2007; 93(5):526; author reply 526. PubMed ID: 18038893
[No Abstract] [Full Text] [Related]
17. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.
Hingtgen S; Ren X; Terwilliger E; Classon M; Weissleder R; Shah K
Mol Cancer Ther; 2008 Nov; 7(11):3575-85. PubMed ID: 19001440
[TBL] [Abstract][Full Text] [Related]
18. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
19. Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.
Le Calvé B; Rynkowski M; Le Mercier M; Bruyère C; Lonez C; Gras T; Haibe-Kains B; Bontempi G; Decaestecker C; Ruysschaert JM; Kiss R; Lefranc F
Neoplasia; 2010 Sep; 12(9):727-39. PubMed ID: 20824049
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model.
Zhang YH; Yue ZJ; Zhang H; Tang GS; Wang Y; Liu JM
Eur J Pharm Biopharm; 2010 Nov; 76(3):371-5. PubMed ID: 20816959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
